Bafna Pharmaceuticals reports standalone net profit of Rs 3.39 crore in the June 2025 quarter
Sales rise 4.00% to Rs 34.62 crore
Net profit of Bafna Pharmaceuticals reported to Rs 3.39 crore in the quarter ended June 2025 as against net loss of Rs 0.72 crore during the previous quarter ended June 2024. Sales rose 4.00% to Rs 34.62 crore in the quarter ended June 2025 as against Rs 33.29 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales34.6233.29 4 OPM %14.643.63 -PBDT4.761.07 345 PBT3.39-0.37 LP NP3.39-0.72 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content